Agiliti Announces Definitive Agreement to Acquire Sizewise
Combination expands Agiliti’s end-to-end service offering to customers, strengthening capabilities in high-demand specialty equipment services
- Complementary product and operational capabilities broaden offering within growing specialty beds, surfaces and mobility equipment market
- Builds on Agiliti’s nationwide footprint and logistics infrastructure, increasing local market presence and creating cross-selling opportunities
- All-cash, stock purchase transaction valued at
- Expected to generate
$5 millionannual cost synergies in the first year, growing to $15 millionby year three
Sizewise is a leading manufacturer and provider of specialized bed frames, therapeutic surfaces and mobility equipment serving more than 3,000 customers in the acute and post-acute care markets with products that address the needs of bariatric, geriatric, pediatric and standard patient populations. For the twelve months ended
“We are pleased to welcome the Sizewise team and their customers to
The combination enables
The company believes the transaction provides several key benefits:
Builds on Agiliti’s unique, at-scale infrastructure, optimizing the companies’ complementary distributed operations networks—including facilities, vehicles, staff, products and operating systems—which will help increase local market presence and support meaningful operating synergies.
Strengthens Agiliti’s capabilities in the supply chain, permitting greater control over R&D, manufacturing and logistics for a vital and differentiated product category.
Expands Agiliti’s value proposition with the exceptional market reputation and deep expertise that Sizewise is known for, to further address the clinical needs of bariatric patients and those at risk of skin and fall injury.
Aligns with Agiliti’s proven, end-to-end service model, providing best-in-class, high-utilization devices delivered within a comprehensive service framework.
“Sizewise has spent the past 25 years engineering, manufacturing, and selling products and service solutions that drive value for our healthcare partners,” said
Cozen O’Connor is serving as legal advisor to
Sizewise is a privately owned, global medical equipment manufacturer with more than 25 years engineering innovative products to meet the needs of bariatric, geriatric, pediatric, and standard patient populations. Produced in four manufacturing plants and supplied through more than 65 branches nationwide, Sizewise offers a range of American-made specialty surfaces, bed frames, and mobility devices that enhance patient healing and caregiver satisfaction. Sizewise is headquartered in
|The reconciliation of Sizewise's last twelve months net income to adjusted EBITDA is as follows:|
|Depreciation and amortization|
|Management & other expenses|
EBITDA is defined as earnings before interest expense, income taxes, depreciation and amortization. Adjusted EBITDA is defined as EBITDA excluding non-cash shared-based compensation expense, management fees and other non-recurring gains, expenses or losses, transaction costs, remeasurement of the tax receivable agreement and loss on extinguishment of debt. In addition to using EBITDA and Adjusted EBITDA internally as measures of operational performance, we disclose them externally to assist analysts, investors and lenders in their comparisons of operational performance, valuation and debt capacity across companies with differing capital, tax and legal structures. We believe the investment community frequently uses EBITDA and Adjusted EBITDA in the evaluation of similarly situated companies. Adjusted EBITDA is also used by the Company as a factor to determine the total amount of incentive compensation to be awarded to executive officers and other employees. EBITDA and Adjusted EBITDA, however, are not measures of financial performance under accounting principles generally accepted in